<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JCIS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Clinical and Investigative Surgery</journal-title>
        <abbrev-journal-title abbrev-type="publisher">J. Clin. Invest. Surg.</abbrev-journal-title>
        <abbrev-journal-title abbrev-type="pubmed">J Clin Invest Surg</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2559-5555</issn>
      <publisher>
        <publisher-name>ProScholar Media</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.25083/2559.5555/7.1.1</article-id>
      <article-id pub-id-type="publisher-id">jcis-7-1-00001</article-id>
      <article-categories>
        <subj-group>
          <subject>Original Research Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The clinical value of IMA and SCUBE1 in the diagnosis of acute appendicitis in children</article-title>
        <alt-title alt-title-type="running-head">IMA and SCUBE1 in the diagnosis of acute appendicitis in children</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Altuntaș</surname>
            <given-names>Mehmet</given-names>
          </name>
          <xref rid="af1-jcis-7-1-00001" ref-type="aff">1</xref>
          <xref rid="c1-jcis-7-1-00001" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Altuntaş</surname>
            <given-names>Gürkan</given-names>
          </name>
          <xref rid="af1-jcis-7-1-00001" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Calapoğlu</surname>
            <given-names>Ahmet Salih</given-names>
          </name>
          <xref rid="af2-jcis-7-1-00001" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bedir</surname>
            <given-names>Recep</given-names>
          </name>
          <xref rid="af3-jcis-7-1-00001" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Atak</surname>
            <given-names>Mehtap</given-names>
          </name>
          <xref rid="af4-jcis-7-1-00001" ref-type="aff">4</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-jcis-7-1-00001"><label>1</label>RECEP TAYYIP ERDOGAN UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF EMERGENCY MEDICINE, RIZE, TURKEY</aff>
      <aff id="af2-jcis-7-1-00001"><label>2</label>RECEP TAYYIP ERDOGAN UNIVERSITY, FACULTY OF MEDICINE. DEPARTMENT OF PEDIATRIC SURGERY, RIZE, TURKEY</aff>
      <aff id="af3-jcis-7-1-00001"><label>3</label>RECEP TAYYIP ERDOGAN UNIVERSITY, FACULTY OF MEDICINE. DEPARTMENT OF PATHOLOGY, RIZE, TURKEY</aff>
      <aff id="af4-jcis-7-1-00001"><label>4</label>RECEP TAYYIP ERDOGAN UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF MEDICAL BIOCHEMISTRY, RIZE, TURKEY</aff>
      <author-notes>
        <corresp id="c1-jcis-7-1-00001"><label>*</label>Correspondence: Mehmet Altuntaș; <email>mehmetaltuntas40@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <volume>7</volume>
      <issue>1</issue>
      <elocation-id>1</elocation-id>
      <fpage>1</fpage>
      <lpage>7</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>12</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>02</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 by the authors.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open access article distributed under the terms and conditions of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="https://www.e-repository.org/jcis/7/1/1.pdf">Full Text PDF</self-uri>
      <abstract>
        <p>Objectives. This study aims to show the clinical value of ischemia-modified albumin (IMA) and Signal Peptide, Complementary C1r/C1s, Uegf and Bmp1–Epidermal Growth Factor Like Domain Containing 1 (SCUBE1) protein in pediatric appendicitis. Methods. Eighty-one pediatric patients hospitalized in the pediatric surgery ward with acute appendicitis and a control group of 62 pediatric patients with unspecific abdominal pain were included in this prospective case-control study. Thirty-nine patients whose pathology specimens confirmed acute appendicitis made up the final appendicitis group. Results. Patients with appendicitis had higher IMA (p&lt;0.001) and SCUBE1 (p&lt;0.001) levels than the control group. In receiver operating characteristic (ROC) analysis, areas under the curve (AUC) were 0.991 (sensitivity=97.4%, specifity=100%, positive likelihood ratio (+LR) infinity, negative likelihood ratio (-LR)=0.03, positive predictive values (+PV)=100%, negative predictive value (-PV)=98.3% for IMA and 0.803 (sensitivity = 89.7%, specificity =64.5%, +LR=2.53, -LR=0.16, +PV=61.4%, -PV=90.9%) for SCUBE1. Conclusions. The present study shows that IMA may be a reliable marker for a more accurate diagnosis of appendicitis. SCUBE1 can be used to exclude diagnosis if used in combination with other laboratory and clinical data.</p>
      </abstract>
      <kwd-group>
        <kwd>acute appendicitis</kwd>
        <kwd>ischemia-modified albumin</kwd>
        <kwd>IMA</kwd>
        <kwd>SCUBE1</kwd>
        <kwd>pediatrics</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="2"/>
        <ref-count count="29"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-jcis-7-1-00001" sec-type="intro">
      <title>Introduction</title>
      <p>Acute appendicitis (AA) is one of the common surgical emergencies in children. The lifetime risk of developing appendicitis is 7-8%, with higher incidences at younger ages [<xref ref-type="bibr" rid="B1-jcis-7-1-00001">1</xref>]. During decision-making process for appendectomy, anamnesis, physical examination, laboratory tests, imaging methods, and clinical decision rules such as Alvarado score are used [<xref ref-type="bibr" rid="B2-jcis-7-1-00001">2</xref>]. However, clinical symptoms, physical examination findings, and radiological characteristics are specific neither for the grade of the disease nor for perforation. In addition, radiological tests have their limitations such as accessibility, high costs, and radiation exposure, especially in the pediatric population. In a recent study that reviewed pediatric literature, the negative appendectomy rates have varied greatly, from 1% to 40% [<xref ref-type="bibr" rid="B3-jcis-7-1-00001">3</xref>].</p>
      <p>Many biomarkers have been studied in the diagnosis of acute appendicitis, such as White blood cell (WBC) count, Absolute neutrophil count (ANC), C-reactive protein (CRP), Erythrocyte Sedimentation Reaction, Tumor Necrosis Alpha, Alpha 1-Glycoprotein, leukocyte elastase complex, Interleukins, granulocyte colony-stimulating factor, tissue inhibitor metalloproteinase-1, serum amyloid A, plasma calprotectin, D-Dimer, and procalcitonin. However, none of these tests have been proved to be precise enough in diagnosing acute appendicitis individually [<xref ref-type="bibr" rid="B2-jcis-7-1-00001">2</xref>, <xref ref-type="bibr" rid="B4-jcis-7-1-00001">4</xref>].</p>
      <p>Ischemia modified albumin (IMA) has recently become a prominent molecule regarding the role of ischemia in the pathophysiology of appendicitis. Hypoxia, acidosis, free radical damage, and membrane degradation cause a structural change in albumin. IMA is a marker formed after damage in the N-terminal region of albumin. The altered N-terminus can no longer bind transition metals, such as cobalt. The causes of the increases in IMA have been shown to be endothelial or extracellular hypoxia, acidosis, and free oxygen radicals [<xref ref-type="bibr" rid="B5-jcis-7-1-00001">5</xref>]. IMA is a well-known biomarker of ischemia in other diseases, including stroke, acute mesenteric ischemia, and acute coronary syndrome [<xref ref-type="bibr" rid="B6-jcis-7-1-00001">6</xref>, <xref ref-type="bibr" rid="B7-jcis-7-1-00001">7</xref>, <xref ref-type="bibr" rid="B8-jcis-7-1-00001">8</xref>, <xref ref-type="bibr" rid="B9-jcis-7-1-00001">9</xref>]. It is also an indicator of oxidative stress, which plays an essential role in the pathogenesis of AA [<xref ref-type="bibr" rid="B10-jcis-7-1-00001">10</xref>, <xref ref-type="bibr" rid="B11-jcis-7-1-00001">11</xref>, <xref ref-type="bibr" rid="B12-jcis-7-1-00001">12</xref>].</p>
      <p>Studies have investigated the diagnostic value of mean platelet volume (MPV) and platelet distribution width (PDW) in acute appendicitis [<xref ref-type="bibr" rid="B13-jcis-7-1-00001">13</xref>]. Signal Peptide, Complementary C1r/C1s, Uegf, and Bmp1-Epidermal Growth Factor Like Domain Containing 1 (SCUBE1) protein is a biomarker that is released from the platelet surface as a result of platelet aggregation. Elevations is SCUBE1 levels have been demonstrated in acute coronary syndrome, ovarian torsion, acute appendicitis, ischemic stroke, and acute mesenteric stroke [<xref ref-type="bibr" rid="B14-jcis-7-1-00001">14</xref>, <xref ref-type="bibr" rid="B15-jcis-7-1-00001">15</xref>, <xref ref-type="bibr" rid="B16-jcis-7-1-00001">16</xref>, <xref ref-type="bibr" rid="B17-jcis-7-1-00001">17</xref>].</p>
      <p>The study's primary aim was to compare IMA and SCUBE1 values between pediatric patients with pathologically confirmed acute appendicitis and nonspecific abdominal pain.</p>
    </sec>
    <sec id="sec2-jcis-7-1-00001" sec-type="methods">
      <title>Materials and Methods</title>
      <p>Patient Selection The study was approved by the Clinical Researches Ethics Committee (2017/108). Eighty-one patients admitted to our hospital’s Emergency Department (ED) with abdominal pain and were hospitalized in our pediatric surgery wards with the presumptive diagnosis of AA after anamnesis, physical examination, laboratory tests, and ultrasonography was included in the study. Ten patients were excluded from the study due to missing laboratory tests. Fifty-four of the hospitalized patients were operated. Thirty-nine patients whose pathology results confirmed acute appendicitis were included in the study.</p>
      <p>The control group consisted of 62 pediatric patients who applied to the ED with unspecific abdominal pain within the study period, for who the diagnosis of acute appendicitis was excluded by anamnesis, physical examination, laboratory tests, and ultrasonography.</p>
      <p>The informed consent form was taken from the individuals and their families in the study and control groups.</p>
      <p>Collection and storage of blood samples Venous blood samples taken from the patients routinely during emergency service admissions were taken into anticoagulant-free biochemistry tubes under CLSI GP41- A6 guidelines. Blood samples for serum were centrifuged at 4000 rpm for 10 minutes after coagulation was completed. After the centrifuge, routine tests requested from the patients were studied immediately and the excess serum samples were kept at -80 ºC until the study day.</p>
      <p>Biochemistry and hemogram measurement Serum biochemistry parameters were studied in the Abbott Architect c16000 autoanalyzer which makes spectrophotometric measurement by using commercial kits. Hemogram was studied from complete blood by using flow cytometry method in Sysmex XN-1000 autoanalyzer.</p>
      <p>Serum IMA Determination study protocol Ischemia modified albumin (IMA) determination was made according to cobalt-albumin binding (CAB) method. According to this method, 3 µL 0.5% CoCl2x6H2O and 131.8 µL of NaH2PO4 with 7.4 of 75 mM pH were put on 40 µL serum sample and vortexed and left for incubation at room temperature for 10 minutes. Following incubation, 5.2 µL and 20 µL 0.9 % NaCl from 7.5 mg/mL DTT was added on the samples and left for incubation for 2 minutes. Water was put instead of DTT as blind sample. The results were read at 470 nm and given as absorbance.</p>
      <p>SCUBE 1 Determination ELISA Kits Study Protocol Serum SCUBE1 was measured with sandwich immunoassay (Enzyme-Linked Immunosorbent Assay (ELISA)) method. Commercially purchased Human SCUBE 1 (cat no: E-EL-H5405) ELISA kits were used in analyses.</p>
      <p>Evaluation of pathological preparations In our study, all of the preparations were evaluated and reported by a senior faculty pathologist blinded to test results. According to pathology results, appendicitis groups were classified as acute appendicitis - Stage 1, acute suppurative appendicitis - Stage 2, acute gangrenous appendicitis - Stage 3 and perforated acute gangrenous appendicitis - Stage 4.</p>
      <p>Statistical Analysis The normal distribution of continuous data was tested with the Kolmogorov Smirnov test, Histogram, and Q-Q plots. Parametric data were reported as mean (X) and standard deviation (SD), nonparametric data were reported as median and interquartile range [IQR (25%-75%)], and categorical variables were reported as number and frequency (%).</p>
      <p>Student t test was used to analyze continuous variables as in the comparison of IMA and SCUBE1 levels between pathologically confirmed acute appendicitis and healthy control groups. Pearson’s Chi-square test was used to compare categorical variables. Receiver operating characteristic (ROC) curve analysis was conducted for continuous variables and the areas under the curve (AUC) were calculated.</p>
      <p>Cut-off points were determined using the Youden index and diagnostic value criteria were calculated with 95% confidence intervals. Significance was accepted as p &lt;0.05 in statistical analysis. All analyses were made with R based Jamovi statistical program (version 1.1.5.0; https://jamovi.org) and Statistical Package for Social Sciences (SPSS version 26).</p>
    </sec>
    <sec id="sec3-jcis-7-1-00001" sec-type="results">
      <title>Results</title>
      <p>In this study, 69.2% (n=27) of the patients in the appendicitis group and 51.6% (n=32) of the patients in the control group were male. The mean age of the appendicitis group was 11.5±4.2 years, while the mean age of the control group was 10.8±3.9 years. Age and gender were not significantly different between the appendicitis group and the control group (p=0.398). Table 1 shows the comparison of demographic data and laboratory data between the patients in the appendicitis group and the patients in the control group.</p>
      <p>Variables n Mean ±SD p value</p>
      <p>Age</p>
      <p>Appendicitis 39 11.5 4.2</p>
      <p>0.398 Control 62 10.8 3.9</p>
      <p>Total 101 11.1 4.1</p>
      <p>Gender (Male) Appendicitis 27 69.2% -</p>
      <p>0.080 Control 32 51.6% -</p>
      <p>WBC (cells /mm3) Appendicitis 39 16458.7 5181.9 &lt;0.001 Control 60 8106.5 1527.6</p>
      <p>ANC (cells /mm3) Appendicitis 39 12531.9 5522.1</p>
      <p>&lt;0.001 Control 60 4150.5 1332.5</p>
      <p>IMA (AbsU) Appendicitis 39 0.86 0.09 &lt;0.001 Control 57 0.57 0.06</p>
      <p>SCUBE1 (ng/ml) Appendicitis 39 25.46 8.59</p>
      <p>&lt;0.001 Control 62 14.68 8.88 WBC: White Blood Count, ANC: Absolute Neutrophil Count, IMA: Ischemia-modified Albumin, SCUBE1: Signal Peptide, Complementary C1r / C1s. Uegf and Bmp1 - Epidermal Growth Factor Like Domain Containing 1 protein, ± SD: Standard Deviation The data of 39 patients whose pathological examinations were compatible with acute appendicitis were determined as 15 (27.8%) patients Stage 1, 20 (37.0%) patients Stage 2, 2 (3.7%) patients Stage 3, and 2 (3.7%) patients Stage 4. IMA and SCUBE1 measurements of the appendicitis group were significantly higher than those of the control group (p&lt;0.001). The diagnostic values of statistically significant parameters were evaluated using ROC analysis. In the appendicitis group, AUC was above 0.900 for WBC, ANC, and IMA and above 0.800 for SCUBE1. ROC curves for laboratory data are given in Figure 1.</p>
      <p>Cut-off values for IMA and SCUBE1 were calculated from the respective ROC curves. The cut-off value of 0.69 AbsU for IMA had a sensitivity of 97.4% and a specificity of 100% (AUC=0.991; 95% CI=0.973-1.000; p&lt;0.001). For SCUBE1, the cut-off value of 15.94 ng/ml had a sensitivity of 89.7% and a specificity of 64.5% (AUC=0.803; 95% CI=0.716-0.890; p&lt;0.001). While a 98.3% (89.1-99.7) negative predictive value was found for IMA, this rate was 90.9% (78.3-97.5) for SCUBE1, 95.2% (86.7-99.0) for WBC, and 93.7% (84.5-98.2) for ANC. Table 2 shows areas under the curve (AUC), cut-off values, sensitivities, specificities, positive predictive values (+PV), negative predictive values (- PV), positive likelihood ratio (+LR), negative likelihood ratio (-LR), and p values in the prediction of AA.</p>
      <p>Metric WBC ANC IMA SCUBE1</p>
      <p>AUC ±SE</p>
      <p>(95% CI)</p>
      <p>0.985±0.010 (0.965-1.000)</p>
      <p>0.942±0.035 (0.873-1.00)</p>
      <p>0.991±0.009 (0.973-1.000)</p>
      <p>0.803±0.044 (0.716-0.890)</p>
      <p>Cut off value 10760 cells/mm³ 6960 cells /mm³ 0.69 AbsU 15.94 ng/ml</p>
      <p>Sensitivity (95 %</p>
      <p>CI)</p>
      <p>92.3 (79.1-98.4)</p>
      <p>89.7 (75.8-97.1)</p>
      <p>97.4 (86.5-99.9)</p>
      <p>89.7 (75.8-97.1)</p>
      <p>Specificity (95 %</p>
      <p>Cl)</p>
      <p>100.0 (94-100)</p>
      <p>98.3 (91.1-99.9)</p>
      <p>100.0 (93.73-100)</p>
      <p>64.5 (51.3-76.3)</p>
      <p>+PV (95 % Cl)</p>
      <p>100.0 (90.3-100)</p>
      <p>97.2 (85.5-99.9)</p>
      <p>100.0 (90.1-100)</p>
      <p>61.4 (47.6-74.0)</p>
      <p>-PV (95 % Cl)</p>
      <p>95.2 (86.7-99.0)</p>
      <p>93.7 (84.5-98.2)</p>
      <p>98.3 (89.1-99.7)</p>
      <p>90.9 (78.3-97.5)</p>
      <p>+LR (95 % Cl) Inf 53.8 (7.69-377.1) Inf 2.53 (1.78-3.6)</p>
      <p>-LR (95 % Cl)</p>
      <p>0.08 (0.03-0.24)</p>
      <p>0.10 (0.04-0.25)</p>
      <p>0.03 (0-0.21)</p>
      <p>0.16 (0.06-0.41)</p>
      <p>Accuracy (95 % Cl) 96.9 (91.4- 99.4)</p>
      <p>94.9 (88.6-98.3)</p>
      <p>98.9 (94.3-99.9)</p>
      <p>74.3 (64.6-82.4)</p>
      <p>p value a &lt; 0.001 &lt; 0.001 &lt; 0.001 &lt; 0.001 WBC: White Blood Count, ANC: Absolute Neutrophil Count, IMA: Ischemia-modified Albumin, SCUBE1: Signal Peptide, Complementary C1r / C1s, Uegf and Bmp1 (CUB)- Epidermal Growth Factor (EGF) Like Domain Containing 1 protein, AUC: Area Under Curve, CI: Confidence Interval, LR: Likelihood Ratios, PV: Predictive Values, İnf: İnfinity, a: The values in groups were calculated by using ROC curve.</p>
      <table-wrap id="T1-jcis-7-1-00001">
        <label>Table 1</label>
        <caption>
          <p>Comparison of demographics and laboratory data between the appendicitis and the control groups</p>
        </caption>
      </table-wrap>
      <fig id="F1-jcis-7-1-00001">
        <label>Figure 1</label>
        <caption>
          <p>Receiver operating characteristic (ROC) curve analyses of important parameters for the diagnosis of appendicitis (WBC, ANC, IMA and SCUBE1)</p>
        </caption>
      </fig>
      <table-wrap id="T2-jcis-7-1-00001">
        <label>Table 2</label>
        <caption>
          <p>Diagnostic accuracy metrics of WBC, ANC, IMA, and SCUBE1 in diagnosis of acute appendicitis</p>
        </caption>
      </table-wrap>
    </sec>
    <sec id="sec4-jcis-7-1-00001" sec-type="discussion">
      <title>Discussion</title>
      <p>Appendicitis is an important cause of abdominal pain in children however misdiagnosis rates are high despite diagnostic advances [<xref ref-type="bibr" rid="B3-jcis-7-1-00001">3</xref>].</p>
      <p>Previously, a large number of biomarkers have been examined as indicators of appendicitis. Phospholipase A2, serum amyloid A, interleukins, cytokines, bilirubin, procalcitonin, and D-dimer have been investigated for diagnosis, and the authors indicated their lower diagnostic accuracy [<xref ref-type="bibr" rid="B2-jcis-7-1-00001">2</xref>, <xref ref-type="bibr" rid="B4-jcis-7-1-00001">4</xref>, <xref ref-type="bibr" rid="B18-jcis-7-1-00001">18</xref>].</p>
      <p>Regardless of age, WBC and ANC are the most frequently used diagnostic laboratory tests in diagnosing appendicitis in children admitted to the ED with acute abdominal pain. An increased WBC count rises the likelihood of appendicitis; however, a normal WBC does not exclude the diagnosis [<xref ref-type="bibr" rid="B19-jcis-7-1-00001">19</xref>]. While a normal WBC count has a 95.6% negative predictive value in children younger than four years of age, the negative predictive value for children between 4 and 12 years of age is 89.5%. The negative predictive value of a low or normal WBC count is 92% among adolescents [<xref ref-type="bibr" rid="B20-jcis-7-1-00001">20</xref>]. In other studies, in which preoperative WBC and ANC values were examined in appendicitis cases, WBC and ANC levels were significantly higher when compared with control groups (p&lt;0.001) [<xref ref-type="bibr" rid="B21-jcis-7-1-00001">21</xref>, <xref ref-type="bibr" rid="B22-jcis-7-1-00001">22</xref>]. In Sengul et al.’s study [<xref ref-type="bibr" rid="B23-jcis-7-1-00001">23</xref>], AUC were 0.708 and 0.699, cut-off values of 10600 cells/mm³ and 8170 cells/mm³ were calculated with sensitivities of 72.2% and 70.7% and specificities of 60.0% and 73.3% for WBC and ANC, respectively. Sevinç et al. [<xref ref-type="bibr" rid="B24-jcis-7-1-00001">24</xref>] analyzed 3.392 acute appendicitis cases and calculated a WBC cut-off value of 11.900 cells/mm3 (sensitivity 71.2%; specificity 67.2%).</p>
      <p>In our study, mean WBC (cells/mm³) counts were 16458.7±5181.9 and 8106.5±1527.6 in the appendicitis group and control group (p&lt;0.001). The following values were determined in the evaluation of the ROC curve for WBC in the prediction of appendicitis cases; Cut-off=10760 cells/mm³, AUC=0.985, sensitivity=92.3%, specificity=100%. Mean ANC (cells/mm³) values were 12531.9±5522.1 and 4150.5±1332.5 in the appendicitis and control group, respectively, and this difference between the groups was statistically significant (p&lt;0.001). The following values were determined in the evaluation of the ROC curve for ANC in the prediction of appendicitis cases; Cut-off=6960 cells/mm³, AUC=0.942, sensitivity =89.7% and specificity=98.3%. In the present study, in parallel with the literature, WBC and ANC values in the appendicitis group were significantly higher compared with the control group. Free radical damage in AA increases IMA levels which can be used in the diagnosis of appendicitis [<xref ref-type="bibr" rid="B5-jcis-7-1-00001">5</xref>, <xref ref-type="bibr" rid="B11-jcis-7-1-00001">11</xref>]. There are few studies in the literature evaluating IMA levels in appendicitis [<xref ref-type="bibr" rid="B10-jcis-7-1-00001">10</xref>, <xref ref-type="bibr" rid="B25-jcis-7-1-00001">25</xref>, <xref ref-type="bibr" rid="B26-jcis-7-1-00001">26</xref>]. Yeniocak et al. [<xref ref-type="bibr" rid="B27-jcis-7-1-00001">27</xref>], in their study, stated that serum IMA levels in patients who applied to the ED with the complaint of abdominal pain could be an indicator of surgery or a clue of complicated cases, especially in terms of acute appendicitis and ovarian pathologies.</p>
      <p>In their study on 65 patients who underwent appendectomy and 30 control patients, Dumlu et al. [<xref ref-type="bibr" rid="B28-jcis-7-1-00001">28</xref>] evaluated the two groups for IMA levels and found a mean IMA level of 0.64±0.09 AbsU in appendicitis cases and a mean level of 0.31±0.09 AbsU in controls (p&lt;0.001). The studies conducted on IMA levels of pediatric patients are limited [<xref ref-type="bibr" rid="B11-jcis-7-1-00001">11</xref>, <xref ref-type="bibr" rid="B12-jcis-7-1-00001">12</xref>]. In a study by Nazik et al. [<xref ref-type="bibr" rid="B11-jcis-7-1-00001">11</xref>], the mean IMA level was 0.56±0.1 AbsU in appendicitis cases and 0.33±0.1 AbsU in controls (p&lt;0.001). In their ROC analysis, a cut-off of 0.445 AbsU was calculated; AUC was 0.99; sensitivity was 96.7% and specificity was 99.7%.</p>
      <p>In our study, mean IMA values were 0.86±0.09 AbsU and 0.57±0.06 AbsU, in the appendicitis and the control group, respectively (p&lt;0.001). For IMA, the calculated cut-off point was 0.69 AbsU; AUC was 0.991; sensitivity was 97.4%, and specificity was 100%. In the present study, the mean IMA value was significantly higher in appendicitis patients. Based on these findings, IMA may perform better than other inflammatory markers in predicting appendicitis cases.</p>
      <p>The secondary aim of this study was to find out the value of SCUBE1 as a diagnostic marker in AA. SCUBE1 was initially shown to be an inflammatory marker and the only known source of SCUBE1 was endothelial cells. Tu et al. [<xref ref-type="bibr" rid="B29-jcis-7-1-00001">29</xref>] showed higher secretion rates of SCUBE1 from activated platelets. In a study conducted by Sonmez et al. [<xref ref-type="bibr" rid="B17-jcis-7-1-00001">17</xref>] on 47 adult AA patients and 43 controls, the difference between SCUBE1 levels in the patient and control groups was not statistically significant (p=0.209). However, SCUBE1 was significantly higher in the CRP positive group (p=0.048).</p>
      <p>In our study, mean SCUBE1 values in the appendicitis and the control group were 25.46±8.59 ng/ml and 14.68±8.88 ng/ml, respectively, and this difference was statistically significant (p&lt;0.001). For SCUBE1, the calculated cut-off point was 15.94 ng/ml, AUC was 0.803, sensitivity was 89.7%, specificity was 64.5%, positive LR was 2.53, and negative LR was 0.16. In the light of these data, with its high negative predictive value, moderate negative LR, and moderate to high sensitivity, SCUBE1 alone does not perform sufficiently to exclude acute appendicitis. Likewise, it cannot be used for diagnosing acute appendicitis due to its moderate positive predictive value, specificity, and positive LR rates. Hence, a combination of SBUBE1 and other laboratory and clinical findings may perform better for the diagnosis of AA. To the best of our knowledge, the present study is the first of its kind on the diagnostic value of SCUBE1 in AA in the pediatric age group.</p>
      <p>Our study's most important limitation is that it is single centered, and the sample size is small. However, we believe that this did not have a negative effect on the diagnostic value of biomarkers in AA diagnosis, which is the primary aim of our study. The most important result of this limitation is the fact that we could not examine the significance of biomarkers in understanding the severity of acute appendicitis since the number of cases was insufficient in pathological stage sub-groups.</p>
    </sec>
    <sec id="sec5-jcis-7-1-00001" sec-type="conclusions">
      <title>Conclusions</title>
      <p>In pediatric patients with abdominal pain, WBC, ANC, and IMA levels might be used in the diagnosis of acute appendicitis. Additionally, SCUBE1 might be useful in ruling out acute appendicitis. However, the role of these biomarkers is not superior to the clinical assessment of patients. Therefore, emergency physicians and surgeons should use them in combination with other clinical findings in the decision-making of acute appendicitis.</p>
    </sec>
  </body>
  <back>
    <notes notes-type="conflict-of-interest">
      <title>Conflict of interest disclosure</title>
      <p>There are no known conflicts of interest in the publication of this article. The manuscript was read and approved by all authors.</p>
    </notes>
    <notes notes-type="ethics">
      <title>Compliance with ethical standards</title>
      <p>Any aspect of the work covered in this manuscript has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript.</p>
    </notes>
    <ack>
      <title>Acknowledgments</title>
      <p>We want to thank the Department of Emergency Medicine for their hard work on their help in data collection. Authors gratefully acknowledge the financial support provided by Recep Tayyip Erdogan University, Scientiﬁc Research Projects Coordinator Unit (BAP) (Project No: RTEU-TSA-2018-927). We thank Nazmiye Çelik from Penn State University (PA, USA) Engineering Science and Mechanics Department for her support with the statistical analyses and typesetting.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-jcis-7-1-00001">
        <label>1</label>
        <mixed-citation publication-type="journal">Rentea RM, St Peter SD. Pediatric Appendicitis. Surg Clin North Am. Feb;97(1):93-112. doi: 10.1016/j.suc.2016.08.009</mixed-citation>
      </ref>
      <ref id="B2-jcis-7-1-00001">
        <label>2</label>
        <mixed-citation publication-type="journal">Alvarado A. Inflammatory Markers in Acute Appendicitis: Are we Still Looking for the Philosopher’s Stone? J Surg. 2018;6(2):1-5. doi: 10.29011/2575-9760.001104</mixed-citation>
      </ref>
      <ref id="B3-jcis-7-1-00001">
        <label>3</label>
        <mixed-citation publication-type="journal">Maloney C, Edelman MC, Bolognese AC, Lipskar AM, Rich BS. The Impact of Pathological Criteria on Pediatric Negative Appendectomy Rate. J Pediatr Surg. 2019;54(9):1794-9. doi: 10.1016/j.jpedsurg.2018.10.106</mixed-citation>
      </ref>
      <ref id="B4-jcis-7-1-00001">
        <label>4</label>
        <mixed-citation publication-type="journal">Naqvi SA, Thompson GC, Joffe AR, Blackwood J, Martin DA, Brindle M, Barkema HW, Jenne CN. Cytokines and Chemokines in Pediatric Appendicitis: A Multiplex Analysis of Inflammatory Protein Mediators. Mediators Inflamm. 2019 Feb 21;2019: 2359681. doi: 10.1155/2019/2359681</mixed-citation>
      </ref>
      <ref id="B5-jcis-7-1-00001">
        <label>5</label>
        <mixed-citation publication-type="journal">Erenler AK, Yardan T, Kati C, Altuntaş M, Türedi S. Role of ischemia-modified albumin in clinical practice. LaboratoriumsMedizin. 2015;39(4):241-247. doi: 10.1515/labmed-2015-0038</mixed-citation>
      </ref>
      <ref id="B6-jcis-7-1-00001">
        <label>6</label>
        <mixed-citation publication-type="journal">Ozgunay SE, Ozsin KK, Ustundag Y, Karasu D, Ozyaprak B, Balcı B, Erel O, Yavuz S. The Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and Albumin-Adjusted Ischemia- Modified Albumin During Cardiopulmonary Bypass. Braz J Cardiovasc Surg. 2019 Aug 27;34(4):436-443. doi: 10.21470/1678-9741-2018-0398</mixed-citation>
      </ref>
      <ref id="B7-jcis-7-1-00001">
        <label>7</label>
        <mixed-citation publication-type="journal">Menon B, Ramalingam K, Krishna V. Study of Ischemia Modified Albumin as a Biomarker in Acute Ischaemic Stroke. Ann Neurosci. 2018 Dec;25(4):187- 190. doi: 10.1159/000488188</mixed-citation>
      </ref>
      <ref id="B8-jcis-7-1-00001">
        <label>8</label>
        <mixed-citation publication-type="journal">Bonorino NF, Lunardelli A, Oliveira JR. Use of ischemia modified albumin for the diagnosis of myocardial infarction. J Bras Patol Med Lab. 2015; 51(6):383-388. https://www.jbpml.org.br/article/4003/</mixed-citation>
      </ref>
      <ref id="B9-jcis-7-1-00001">
        <label>9</label>
        <mixed-citation publication-type="journal">Demir MT, Baydin A, Amanvermez R, Erenler AK, Güzel M, Yücel O. Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome. Bratisl Lek Listy. 2018;119(8):509-512. doi: 10.4149/BLL_2018_093</mixed-citation>
      </ref>
      <ref id="B10-jcis-7-1-00001">
        <label>10</label>
        <mixed-citation publication-type="journal">Kılıç MÖ, Güldoğan CE, Balamir İ, Tez M. Ischemia-modified albumin as a predictor of the severity of acute appendicitis. Am J Emerg Med. 2017 Jan;35(1):92-95. doi: 10.1016/j.ajem.2016.10.010</mixed-citation>
      </ref>
      <ref id="B11-jcis-7-1-00001">
        <label>11</label>
        <mixed-citation publication-type="journal">Nazik S, Avci V, Küskü Kiraz Z. Ischemia-modified albumin and other inflammatory markers in the diagnosis of appendicitis in children. Ulus Travma Acil Cerrahi Derg. 2017 Jul;23(4):317-321. doi: 10.5505/tjtes.2016.11823</mixed-citation>
      </ref>
      <ref id="B12-jcis-7-1-00001">
        <label>12</label>
        <mixed-citation publication-type="journal">Ulusoy E, Çitlenbik H, Akgül F, Öztürk A, Şık N, Ulusoy O, Küme T, Yılmaz D, Duman M. Is Ischemia- Modified Albumin a Reliable Marker in Accurate Diagnosis of Appendicitis in Children? World J Surg. 2020 Apr;44(4):1309-1315. doi: 10.1007/s00268-019- 05323-1</mixed-citation>
      </ref>
      <ref id="B13-jcis-7-1-00001">
        <label>13</label>
        <mixed-citation publication-type="journal">Dinc B, Oskay A, Dinc SE, Bas B, Tekin S. New parameter in diagnosis of acute appendicitis: platelet distribution width. World J Gastroenterol. 2015 Feb 14;21(6):1821-6. doi: 10.3748/wjg.v21.i6.1821</mixed-citation>
      </ref>
      <ref id="B14-jcis-7-1-00001">
        <label>14</label>
        <mixed-citation publication-type="journal">Turkmen S, Mentese S, Mentese A, Sumer AU, Saglam K, Yulug E, Turedi S, Gunduz A. The value of signal peptide-CUB-EGF domain-containing protein 1 and oxidative stress parameters in the diagnosis of acute mesenteric ischemia. Acad Emerg Med. 2013 Mar; 20(3):257-64. doi: 10.1111/acem.12096</mixed-citation>
      </ref>
      <ref id="B15-jcis-7-1-00001">
        <label>15</label>
        <mixed-citation publication-type="journal">Sonmez E, Turkdogan KA, Karabacak M, Civelek C, Yilmaz C, Ozer OF, Çavuş UY. The diagnostic role of signal peptide-C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 in non-ST-elevation acute coronary syndrome. Am J Emerg Med. 2015 Jan;33(1):21-4. doi: 10.1016/j.ajem.2014.09.047</mixed-citation>
      </ref>
      <ref id="B16-jcis-7-1-00001">
        <label>16</label>
        <mixed-citation publication-type="journal">Gunaydin M, Sipahi M, Kesicioglu T, Usta M, Tezcan B, Tokgoz VY. The value of plasma SCUBE1 and oxidative stress parameters in the early diagnosis of acute ovarian torsion. Bratisl Lek Listy. 2019;120(6): 456-461. doi: 10.4149/BLL_2019_073</mixed-citation>
      </ref>
      <ref id="B17-jcis-7-1-00001">
        <label>17</label>
        <mixed-citation publication-type="journal">Sonmez E, Dursun A, Gulen B, Metin H, Ozer OF. The Diagnostic Value of SCUBE1 in Acute Appendicitis. Clin Lab. 2017 Mar 1;63(3):453-459. doi: 10.7754/Clin.Lab.2016.160729</mixed-citation>
      </ref>
      <ref id="B18-jcis-7-1-00001">
        <label>18</label>
        <mixed-citation publication-type="journal">Kaya B, Sana B, Eris C, Karabulut K, Bat O, Kutanis R. The diagnostic value of D-dimer, procalcitonin and CRP in acute appendicitis. Int J Med Sci. 2012;9(10): 909-15. doi: 10.7150/ijms.4733</mixed-citation>
      </ref>
      <ref id="B19-jcis-7-1-00001">
        <label>19</label>
        <mixed-citation publication-type="journal">Grönroos P, Huhtinen H, Grönroos JM. Normal leukocyte count and C-reactive protein value do not effectively exclude acute appendicitis in children. Dis Colon Rectum. 2009 May;52(5):1028-9; author reply 1029. doi: 10.1007/DCR.0b013e3181a51018</mixed-citation>
      </ref>
      <ref id="B20-jcis-7-1-00001">
        <label>20</label>
        <mixed-citation publication-type="journal">Wang LT, Prentiss KA, Simon JZ, Doody DP, Ryan DP. The use of white blood cell count and left shift in the diagnosis of appendicitis in children. Pediatr Emerg Care. 2007;23(2):69-76. doi: 10.1097/PEC.0b013e31802d1716</mixed-citation>
      </ref>
      <ref id="B21-jcis-7-1-00001">
        <label>21</label>
        <mixed-citation publication-type="journal">Ulukent SC, Sarici IS, Ulutas KT. All CBC parameters in diagnosis of acute appendicitis. Int J Clin Exp Med. 2016;9(6):11871-11876.</mixed-citation>
      </ref>
      <ref id="B22-jcis-7-1-00001">
        <label>22</label>
        <mixed-citation publication-type="journal">Zani A, Teague WJ, Clarke SA, Haddad MJ, Khurana S, Tsang T, Nataraja RM. Can common serum biomarkers predict complicated appendicitis in children? Pediatr Surg Int. 2017 Jul;33(7):799-805. doi: 10.1007/s00383-017-4088-1</mixed-citation>
      </ref>
      <ref id="B23-jcis-7-1-00001">
        <label>23</label>
        <mixed-citation publication-type="journal">Sengul S, Guler Y, Calis H, Karabulut Z. The Role of Serum Laboratory Biomarkers for Complicated and Uncomplicated Appendicitis in Adolescents. J Coll Physicians Surg Pak. 2020 Apr;30(4):420-424. doi: 10.29271/jcpsp.2020.04.420</mixed-citation>
      </ref>
      <ref id="B24-jcis-7-1-00001">
        <label>24</label>
        <mixed-citation publication-type="journal">Sevinç MM, Kınacı E, Çakar E, Bayrak S, Özakay A, Aren A, Sarı S. Diagnostic value of basic laboratory parameters for simple and perforated acute appendicitis: an analysis of 3392 cases. Ulus Travma Acil Cerrahi Derg. 2016 Mar;22(2):155-62. doi: 10.5505/tjtes.2016.54388</mixed-citation>
      </ref>
      <ref id="B25-jcis-7-1-00001">
        <label>25</label>
        <mixed-citation publication-type="journal">Hakkoymaz H, Nazik S, Seyithanoğlu M, Güler Ö, Şahin AR, Cengiz E, Yazar FM. The value of ischemia-modified albumin and oxidative stress markers in the diagnosis of acute appendicitis in adults. Am J Emerg Med. Nov;37(11):2097-2101. doi: 10.1016/j.ajem.2019.03.005</mixed-citation>
      </ref>
      <ref id="B26-jcis-7-1-00001">
        <label>26</label>
        <mixed-citation publication-type="journal">Turan E, Sevinç B, Kurku H, Simsek G, Demirgül R, Karahan Ö. The role of ischemia-modified albumin levels in the diagnosis of acute appendicitis. Translational Surgery. 2017;2(3):62. doi: 10.4103/ts.ts_13_17</mixed-citation>
      </ref>
      <ref id="B27-jcis-7-1-00001">
        <label>27</label>
        <mixed-citation publication-type="journal">Yeniocak S, Saraç F, Yazıcıoğlu M, Karabulut N, Ünal A, Yücetaş E, Koldaş M, Akkoç İ, Ekici M, Evrin T. The Diagnostic Values of Ischemia-Modified Albumin in Patients with Acute Abdominal Pain and Its Role in Differentiating Acute Abdomen. Emerg Med Int. 2020 May 14;2020:7925975. doi: 10.1155/2020/7925975</mixed-citation>
      </ref>
      <ref id="B28-jcis-7-1-00001">
        <label>28</label>
        <mixed-citation publication-type="journal">Dumlu EG, Tokaç M, Bozkurt B, Yildirim MB, Ergin M, Yalçin A, Kiliç M. Correlation between the serum and tissue levels of oxidative stress markers and the extent of inflammation in acute appendicitis. Clinics (Sao Paulo). 2014 Dec;69(10):677-82. doi: 10.6061/clinics/2014(10)05</mixed-citation>
      </ref>
      <ref id="B29-jcis-7-1-00001">
        <label>29</label>
        <mixed-citation publication-type="journal">Tu CF, Su YH, Huang YN, Tsai MT, Li LT, Chen YL, Cheng CJ, Dai DF, Yang RB. Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res. Aug 1;71(3):486-95. doi: 10.1016/j.cardiores.2006.04.010</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
